期刊文献+

尿激酶型纤溶酶原uPA和P^(27)蛋白在乳腺癌中的表达及其意义 被引量:1

Expression and clinical significance of uPA and P^(27) protein in breast cancer
下载PDF
导出
摘要 目的 探讨正常乳腺组织、良性病变乳腺组织、乳腺癌中uPA和P2 7蛋白的表达水平及其意义。方法 应用免疫组织化学方法对 8例正常乳腺组织、2 4例良性病变乳腺组织及 66例乳腺癌中uPA、P2 7蛋白的表达进行测定。结果 uPA和P2 7蛋白在 66例乳腺癌中的高表达率分别为 5 7.6%、5 3 .0 % ,uPA在乳腺癌中的表达水平明显高于正常和良性病变乳腺组织 (P <0 .0 5 ) ;而P2 7蛋白在乳腺癌的表达水平明显低于正常和良性病变乳腺组织 (P <0 .0 5 )。uPA和P2 7蛋白在乳腺癌中的表达有显著相关性 ,它们与乳腺癌的病理学特征显著相关。结论 P2 7蛋白和uPA的表达水平可能与乳腺癌的发生、发展和预后有关 ,而且对于指导乳腺癌的治疗有一定的临床意义。 ObjectiveTo investigate the expresion and clinical value of uPA and P 27 in breast cancer,normal and benign breast disease tissue.MethodsThe expression of uPA and P 27 in 66 cases of breast cancer,8 cases of normal breast tissue and 24 cases of benign breast disease were detected by immunohistochemical technique.ResultsHigh expression rates of uPA and P 27 in 66 cases of breast cancer were 57.6% and 53.0% respectively.The expression level of uPA in breast cancer was higher than that in normal and benign breast disease tissue (P<0.05),but the expression level of P 27 in breast cancer was lower than that in normal and benign breast disease tissue (P<0.05).The expression of uPA and P 27 in breast cancer had significant correlation.And they were significantly associated with clinicopathological characteristics of breast cancer.ConclusionThe expression of uPA and P 27might play an important role in the carcinogenesis,development,metastasis and prognosis of breast cancer.Furthermore they might have clinical value in the treatment of breast cancer.
出处 《中国肿瘤临床与康复》 2002年第5期31-32,共2页 Chinese Journal of Clinical Oncology and Rehabilitation
关键词 乳腺癌 尿激酶型纤溶酶原uPA P^27蛋白 预后 免疫组织化学 breast cancer urokinase-type plasminogen activator immunohistochemistry P 27protein prognosis
  • 相关文献

参考文献5

  • 1Ossowksi L,Reich E.Antibodies to plasminogen activator in human tumor metastasis[].Cell.1983
  • 2Surrendra P,Lipman J,Goldman H,et al.Loss or altered subcellular localization of P27 in Barrett′s associated adenocarcinoma[].Cancer Research.1998
  • 3Esposited v,Baldi A,Deluca,et al.Prognostic role of cyclindependent kinase inhibitor P27 in non-small cell lung cancer[].Cancer Research.1997
  • 4Solomayer EF,Diel IJ,Wallwiener D,et al.Prognostic relevance of urokinase plasminogen activator detection in micrometastatic cells in the bone marrow of patients with primary breast cancer[].British Journal of Cancer.1997
  • 5Puay T,cady B,Wamer M,et al.The cell cycle inhibitor P27 is an independent prognostic marker in small (T1 a, b) invasive breast carcinomas[].Cancer Research.1997

同被引文献12

  • 1闫慧明,郭艳丽,郑启昌,卢昕,马剑方.应用组织芯片技术研究uPA和uPAR在胰腺癌中的表达[J].山西医科大学学报,2004,35(5):455-457. 被引量:3
  • 2Rabbani SA,Mazar AP.The role of the plasminogen activation system in angiogenesis and metastasis.Surg Clin North Am,2001,10(2):393-415.
  • 3John A,Tuszynski G.The role of matrix metallop roteinases in tumor angiogenesis and tumor mestastasis.Pathol Oncol Res,2001,7 (1):14-23.
  • 4Salh B,Marotta A,Matthewson C,et al.Investigation of the MekMAP Kinase-RSK pathway in human breast cancer.Anti-cancer Res,1999,19 (1 B):731-740.
  • 5Mandell JW,Hussaini G,Zecevie M,et al.In situ visualization of intratumor growth factor signaling:immunohistochemical localization of activated ERK/MAP kinase in glial neoplasma.Am J Pathol,1998,153(5):1411-1423.
  • 6Fromowitz FB,Violo MV,Chao S,et al.RAS p21 expression in the progression of breast cancer.Hum Pathol,1987,18 (12):1268-1275.
  • 7Widmann C,Gibson S,Jarp MB,et al.Mitogen-activated protein kinase:conservation of a three-kinase module from yeast to human.Plysiol Rev,1999,79 (1):143-180.
  • 8Yebra M,Goretzki S,Pfeifer M,et al.Urokinase-type plasminogen activator binding to its receptor stimulates tumor cell migration by enhancing integrin mediated signal transduction.Exp Cell Ress,1999,250:231-240.
  • 9金英姬,宋今丹.UPA在大肠癌中的表达及其与肿瘤侵袭的关系[J].中国肿瘤临床,1998,25(9):630-633. 被引量:5
  • 10徐韶华,廖劲晖,朱运松.尿激酶受体反义RNA抑制人乳腺癌细胞的侵袭作用[J].中国生物化学与分子生物学报,2000,16(6):814-819. 被引量:8

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部